Application 070916
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NALBUPHINE HYDROCHLORIDE | NALBUPHINE HYDROCHLORIDE | INJECTABLE;INJECTION | 20MG/ML | No | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0409-1465 | Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1465 | Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1465 | Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1465 | Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1465 | Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 63739-466 | Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | McKesson Corporation | ANDA | Current |
| 63739-466 | Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | McKesson Corporation dba SKY Packaging | ANDA | Current |